Table 2.
Antioxidant and oxidative parameters of the study population
| Before treatment | After treatment | |
|---|---|---|
| Paraoxonase activity (U l−1) | 108 ± 34 | 129 ± 31* |
| Paraoxonase concentration (µg ml−1) | 57.32 ± 7.17 | 52.82 ± 8.55 |
| Paraoxonase specific activity (U mg−1) | 1.88 ± 0.68 | 2.44 ± 0.83* |
| Paraoxonase/HDL-cholesterol | 114 ± 39 | 107 ± 28 |
| Paraoxonase/apolipoprotein A1 | 80 ± 21 | 73.7 ± 18 |
| Arylesterase activity (U ml−1) | 98 ± 24 | 89 ± 30 |
| Oxidized LDL (U l−1) | 137.4 ± 20.5 | 117.6 ± 18.3** |
| LDL-C/LDL-B | 0.96 ± 0.05 | 1.05 ± 0.06* |
Values are mean ± SD
**
P < 0.001
*
P < 0.05